Routine companion animal appointments represent the highest-volume, lowest-perceived-risk clinical interactions in veterinary practice. They are also the clinical setting with the most documented medical asepsis failures.

The combination of high patient volume, time pressure, and low perceived infection risk consistently produces poor hand hygiene compliance, inconsistent surface disinfection, and inadequate PPE use in exam room settings.

What this covers: The practical application of medical asepsis during routine companion animal examinations, including the WHO Five Moments framework adapted to veterinary appointments, PPE selection, between-patient disinfection, and what the evidence shows about current compliance.Evidence base: A video observation study across 38 Ontario veterinary clinics documented 10,894 hand hygiene opportunities during routine appointments (PMC4108058). A Swiss companion animal clinic study found overall hand hygiene compliance of 36.6% (PMC8623950). Both confirm that compliance during routine exams is substantially below recommended levels.Clinical relevance: Routine exams are the primary setting for patient-to-patient pathogen transmission in companion animal practice. MRSP, MRSA, and MDR gram-negative organisms circulate through exam rooms via inadequate hand hygiene and surface disinfection.

Key takeaways

• Routine exams are high-risk medical asepsis settings, not low-risk ones: High appointment volume and inadequate compliance amplifies transmission risk despite the low-acuity nature of individual appointments.
• Documented hand hygiene compliance in companion animal clinics is approximately 36 to 40%: This means that in the majority of patient contacts, hand hygiene is either not performed or performed incorrectly.
• The exam table is a primary transmission vehicle: Studies in human healthcare settings confirm that contaminated examination surfaces transfer pathogens to subsequently examined patients. The mechanism is identical in veterinary exam rooms.
• ABHR at point of care is the most effective compliance intervention: Placement of ABHR dispensers at the exam room entrance and inside the exam room consistently improves compliance rates in human and veterinary healthcare settings.
• Between-patient disinfection of the exam table and stethoscope is non-negotiable: These surfaces contact every patient and serve as cross-contamination vehicles when not disinfected between patients.
• Clean gloves do not replace hand hygiene: Donning clean gloves without prior hand hygiene and removing gloves without performing hand hygiene afterward both represent medical asepsis failures.

The appointment as an asepsis sequence

A routine companion animal appointment involves multiple patient contacts, each with specific hand hygiene requirements. Mapping the WHO Five Moments to a typical appointment:

Typical appointment structure

A patient is received by a veterinary technician, examined by the veterinarian, and a vaccination is administered.

Hand hygiene moments:

In a typical appointment with one technician and one veterinarian, the Canadian video observation study identified five hand hygiene opportunities. The study observed 10,894 such opportunities across 38 clinics.

Where compliance fails

Published data and observational research consistently identify the same failure patterns:

Most commonly missed moments:

• Moment 2 (before a clean/aseptic procedure): most frequently missed in human and veterinary healthcare data
• Moment 5 (after contact with patient surroundings): frequently omitted because contamination from environmental surfaces is not intuitively associated with patient risk

Most commonly performed moments:

• Moment 4 (after patient contact): performed more reliably because the contamination is perceived as coming directly from the patient

The asymmetry is clinically important: the moments that are skipped are the ones that prevent the staff member from introducing contamination rather than acquiring it.

Applying medical asepsis: step-by-step for a routine exam

Before the appointment

• [ ] Previous patient's exam table disinfected (top, sides, any raised edge)
• [ ] Stethoscope diaphragm and earpieces cleaned with ABHR or appropriate disinfectant
• [ ] Any equipment from previous patient removed or disinfected
• [ ] ABHR available at point of care (inside exam room preferred; entrance as minimum)

On patient arrival

• [ ] Hand hygiene (Moment 1) before touching the patient or their belongings
• [ ] Gloves if indicated (body fluid contact anticipated; patient with known infectious disease)

During the physical examination

• [ ] Examination proceeds with clean technique: no non-indicated glove removal; no touching of non-patient surfaces unnecessarily
• [ ] If gloves are worn: remove before touching clean surfaces (keyboard, record, door handle); perform hand hygiene after removal

Before any invasive step (injection, blood draw, IV catheter)

• [ ] Hand hygiene (Moment 2) if not already wearing gloves; or ensure gloves are on and clean
• [ ] Site antisepsis: clip hair if needed; apply isopropyl alcohol or appropriate antiseptic
• [ ] For IV catheter placement: aseptic site preparation (more rigorous than standard injection site prep)

After examination

• [ ] Hand hygiene (Moment 4) after completing patient contact
• [ ] Hand hygiene (Moment 5) after touching the exam table, leash, carrier, scale, or any patient-zone surface

Between patients

• [ ] Exam table disinfected with hospital-grade disinfectant; contact time observed
• [ ] Stethoscope diaphragm cleaned
• [ ] Any single-use items from previous patient disposed of
• [ ] If infectious disease suspected: enhanced disinfection; all surfaces in patient zone

For medical asepsis principles applied broadly in veterinary clinics, including the five domains of medical asepsis (hand hygiene, PPE, surface disinfection, waste management, and environmental cleaning) with the published compliance data context, that guide covers the full medical asepsis framework.

Minor invasive procedures during routine exams, including IV catheter placement and urinary catheterization, require an aseptic step within the otherwise medical-asepsis context of the appointment. For asepsis for IV catheter placement, including the site preparation, clean technique, and aseptic barrier requirements that apply when catheter placement occurs outside the OR setting, that guide covers the specific asepsis requirements for this common clinic procedure.

The stethoscope problem

The stethoscope is among the most persistently under-disinfected clinical tools in both human and veterinary medicine.

Multiple studies in human healthcare settings have documented stethoscope contamination rates between 80 and 100% in routine clinical use, with organisms including MRSA, Clostridium difficile, and gram-negative pathogens.

In veterinary practice, the stethoscope contacts multiple patients per day, is worn around the neck between patients (contacting clothing and skin), and is rarely disinfected between every patient contact.

Minimum requirement: ABHR applied to the diaphragm between each patient. A single application of 70% isopropyl alcohol (which is present in ABHR) achieves greater than 99% bacterial reduction on stethoscope diaphragm surfaces.

Practical approach: ABHR application to the diaphragm as the last step of each patient encounter, immediately before leaving the exam room.

Point-of-care ABHR: the most impactful compliance intervention

The single environmental factor most consistently associated with improved hand hygiene compliance in both human and veterinary healthcare settings is point-of-care availability of ABHR.

When ABHR requires staff to leave the exam room or walk across the room to a sink, the moment-of-use convenience is lost and compliance drops. When ABHR is within arm's reach at the point of care, the behavioral barrier to compliance is minimized.

Recommended placement:

• Inside each exam room, near the exam table
• Outside exam room entrances
• At ward entry points
• At treatment room entries

Wall-mounted dispensers are preferable to countertop bottles, which can contaminate the hand during pumping if the pump itself is not cleaned regularly.

For how exam asepsis differs from surgical asepsis, including the formal comparison of clean technique vs. sterile technique standards across the full range of veterinary clinical settings, that guide covers the distinction in comprehensive detail.

Infectious disease patients in the routine exam setting

Patients presenting with suspected infectious disease require modified medical asepsis protocols in the exam room:

Enhanced protocols:

• Contact precautions: gown and gloves for all patient contact
• Dedicated exam room if possible; if not, schedule as last patient of day in that room
• Enhanced between-patient disinfection: intermediate-level agent with appropriate contact time
• Patient handled directly from carrier to scale to exam table without floor contact (reduces environmental contamination spread)
• Staff perform hand hygiene after removing gloves and gown; both must be disposed before leaving the exam area

Infectious disease categories of particular concern in companion animal practice:

• Suspected Salmonella or Campylobacter (zoonotic risk)
• Known MRSP colonization
• Respiratory disease (Bordetella, influenza, feline URI pathogens)
• Parvovirus (highly resistant environmental pathogen)
• Giardia and other enteric protozoa (zoonotic risk in immunocompromised owners)

For antisepsis applied in exam settings, including how antiseptic agents used in routine exam procedures (injection site prep, minor wound care) relate to the broader asepsis framework, that guide covers the antisepsis component applicable to routine clinical settings.

Frequently asked questions

Should veterinary staff wear gloves for all routine physical examinations?

No. Routine glove use for every examination without indication is not supported by infection control evidence and may paradoxically reduce hand hygiene compliance (by creating a false sense of protection). Gloves are indicated for contact with body fluids, non-intact skin, mucous membranes, and patients with known infectious disease. For routine examination of a healthy patient, hand hygiene before and after contact is the appropriate medical asepsis approach.

Is it necessary to disinfect the exam table between every patient?

Yes. The exam table is a confirmed pathogen transfer surface. Between-patient disinfection is not optional. Time pressure does not exempt this step; it should be factored into appointment scheduling.

How should we manage an exam room after a patient with suspected parvovirus?

Immediate enhanced disinfection with a parvovirus-effective agent (such as dilute sodium hypochlorite/bleach at appropriate concentration, or an accelerated hydrogen peroxide product with parvovirus label claim). Standard quaternary ammonium compounds are not effective against parvovirus. The room should remain disinfected and the surface wet for the full required contact time before the next patient enters.

What should we do if we discover a staff member has not been performing hand hygiene consistently?

Address this as a training and compliance issue, not a disciplinary one. Provide reinforcement of the Five Moments framework and point-of-care ABHR placement. Monitor compliance prospectively. The response to non-compliance should be educational and systemic rather than punitive, as punitive responses reduce disclosure and worsen overall compliance culture.

Routine appointments are the volume backbone of companion animal practice and the primary site of nosocomial pathogen transmission. The hand hygiene compliance rate of approximately 37% documented in published veterinary studies represents a substantial and addressable patient safety gap. Point-of-care ABHR availability, Five Moments training, and between-patient surface disinfection are the three highest-impact interventions available. None of them are expensive. All of them are consistently underimplemented.

Resources

The following sources were used as reference and background for this article:

• NIH/PMC. Video observation of hand hygiene practices during routine companion animal appointments. pmc.ncbi.nlm.nih.gov
• NIH/PMC. Hand Hygiene Evaluation Using Two Different Tools in a Swiss Companion Animal Clinic. ncbi.nlm.nih.gov
• Australian Veterinary Association. Infection prevention and control in veterinary workplaces. ava.com.au
• WHO. My 5 Moments for Hand Hygiene. who.int
• Merck Veterinary Manual. Overview of Antiseptics and Disinfectants for Use With Animals. merckvetmanual.com

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is the most clinically significant drug-resistant pathogen in veterinary surgical site infections. It cannot be reliably treated with beta-lactam antibiotics, and treatment options when it does occur may be severely limited.

The primary prevention strategy is asepsis. Not antibiotics. Asepsis.

What this covers: How MRSP is transmitted in veterinary surgical settings, why asepsis is the primary prevention strategy, the specific asepsis components most relevant to MRSP control, and how MRSP connects to antimicrobial stewardship.Evidence base: Finnish veterinary teaching hospital MRSP outbreak study (PMC4198203); Veterinary Practice News MRSP carrier rate and biofilm data; BMC Veterinary Research skin asepsis protocol study (PMC5852956); MRSP colonization as SSI risk factor in orthopedic surgery cohort studies.Clinical relevance: MRSP carrier rate in dogs is approximately 4.4%. MRSP-colonized dogs have a 14-times higher SSI infection rate. MRSP produces biofilm that resists both antibiotic penetration and host immune response. Once established in a surgical wound, MRSP infection frequently requires implant removal.

Key takeaways

• MRSP carrier rate in dogs is approximately 4.4%; colonized dogs have 14x higher SSI risk.
• MRSP is transmitted primarily through contact: hands, surfaces, and instruments.
• Strict asepsis is the most effective MRSP prevention strategy available.
• MRSP forms biofilm on implants, making established infections extremely difficult to treat.
• Hand hygiene is the primary barrier to MRSP transmission between patients in clinic settings.
• Antimicrobial prophylaxis does not reliably prevent MRSP SSI: asepsis does.
• MRSP outbreaks in veterinary hospitals are documented and can be severe.

What MRSP is and why it matters

Staphylococcus pseudintermedius is a commensal organism of the canine skin, mucous membranes, and anal sacs. In most dogs it causes no harm. In the context of surgery, it is the most frequent bacterial cause of SSI in small animal practice.

MRSP is the methicillin-resistant variant. It carries the mecA gene, which confers resistance to all beta-lactam antibiotics (penicillins, cephalosporins, carbapenems). MRSP strains commonly acquire resistance to additional antibiotic classes, sometimes leaving only a small number of treatment options.

Clinical consequences of MRSP SSI:

• Infection that does not respond to first-line or commonly used antibiotics
• Prolonged, expensive treatment courses with agents potentially reserved for human critical care
• In orthopedic procedures: biofilm formation on implant surfaces that is not penetrable by antibiotics at achievable concentrations
• Implant removal frequently required to resolve MRSP implant-associated infection
• Prolonged patient morbidity, owner distress, and reputational consequences for the practice

Veterinary Practice News reports: "The most common pathogen involved in small animal surgical site infections today is MRSP. The overall carrier rate is approximately 4.4%, with a 14 times higher infection rate in part due to its ability to develop a biofilm."

How MRSP is transmitted in veterinary settings

MRSP transmission is contact-mediated. This is the central fact that makes asepsis the primary prevention strategy.

Transmission routes:

1. Endogenous (patient's own flora): The most common source. MRSP on the dog's skin or in the nasal or anal carriage is introduced into the wound during or after surgery. Skin antisepsis reduces but does not eliminate this risk.

2. Healthcare worker hands: Hands of veterinary staff colonized with MRSP or contaminated by contact with MRSP-positive patients can transfer MRSP to wounds, instruments, and surfaces. A Finnish MRSP outbreak study (PMC4198203) documented clonal spread of MRSP through a veterinary teaching hospital over 26 months.

3. Environmental surfaces: MRSP can survive on clinical surfaces (exam tables, kennel surfaces, equipment) long enough to contaminate subsequent patients via staff hands or direct contact. The same Finnish study found the outbreak extended through surgery wards and intensive care.

4. Instruments and implants: Non-sterile instruments, or instruments whose sterility was compromised during handling, introduce MRSP directly into the wound.

What this means for prevention:

Every component of asepsis addresses one or more of these routes. Skin antisepsis addresses endogenous flora. Hand hygiene addresses the healthcare worker route. Surface disinfection addresses environmental persistence. Instrument sterilization and aseptic technique address direct wound inoculation.

The MRSP outbreak: what happens when asepsis fails

A Finnish veterinary teaching hospital experienced a large MRSP outbreak lasting 26 months (November 2010 to January 2012). The study (PMC4198203) documented:

• Clonal spread of a multi-drug resistant MRSP strain through the hospital
• Identified risk factors: skin lesion (OR 6.2), prior antimicrobial treatment (OR 3.8), days in ICU (OR 1.3 per day), days in surgery ward (OR 1.1 per day)
• The outbreak required: contact tracing, enhanced hand hygiene, cohorting, barrier nursing, enhanced disinfection, and a search-and-isolate policy on admission

The outcome: a search-and-isolate policy at admission, identifying MRSP-positive patients before surgery, was the intervention that eventually controlled the outbreak.

The prevention lesson: The interventions used to control the outbreak: hand hygiene, barrier nursing, enhanced disinfection, isolation, are the same asepsis principles that would have prevented it. An outbreak forces these practices. Routine asepsis compliance maintains them.

MRSP and biofilm: why prevention is non-negotiable

MRSP produces biofilm: a structured community of bacteria enclosed in a self-produced extracellular matrix. Biofilm formation on orthopedic implants (plates, screws) creates a reservoir of infection that:

• Is physically protected from host immune cell penetration
• Prevents antibiotics from reaching effective concentrations at the bacteria
• Cannot be cleared by systemic antibiotic therapy alone
• Requires removal of the implant (and the biofilm attached to it) to resolve the infection

For TPLO and other implant procedures, the MRSP SSI consequence is not just a prolonged wound infection. It is frequently an infection requiring a second surgery, implant removal, extended convalescence, and in some cases loss of function.

The implication for asepsis: preventing MRSP from entering the wound is infinitely preferable to treating MRSP once it has formed biofilm on an implant. Treatment is difficult. Prevention through asepsis is achievable.

For asepsis during TPLO surgery, including the specific asepsis protocol elements that are most critical for TPLO procedures where MRSP-biofilm risk is highest, that guide covers the TPLO-specific asepsis requirements.

The aseptic technique framework is where all these individual MRSP prevention components come together intraoperatively. For aseptic technique applied to MRSP-risk procedures, including the sterile field rules, instrument handling, double-gloving technique, and OR behavior standards that constitute the intraoperative MRSP prevention protocol, that guide covers the technique framework.

Asepsis components most relevant to MRSP prevention

Skin antisepsis

The BMC Veterinary Research study (PMC5852956) confirmed that both chlorhexidine-alcohol and povidone-iodine skin antisepsis protocols achieved no bacterial growth in 70 to 74% of post-prep samples. The same study found only 4.3% of dogs had methicillin-resistant species detectable pre-operatively on the surgical site.

This means skin antisepsis is highly effective at eliminating most surface MRSP. The residual risk comes from follicular bacteria and from perioperative environmental and instrument contamination.

Surgical hand antisepsis

Healthcare worker hands are a documented MRSP transmission vector. Strict surgical hand antisepsis before every procedure, and hand hygiene between all patient contacts in the clinic, reduces this route.

Zoetis infection control guidance states: "Strict asepsis during surgery including a thorough hand and nail scrubbing with a cleaning and disinfectant agent followed by sterile gowning and gloving is most important in preventing transmission of MRSA/MRSP from the colonized surgeon or assistant to the pet."

Instrument sterilization

MRSP on inadequately sterilized instruments is directly inoculated into the surgical wound. Validated autoclave sterilization with weekly biological indicator testing eliminates this route.

OR traffic control

Personnel entering the OR shed skin cells carrying bacteria including any MRSP they carry. Minimizing OR traffic during implant procedures directly reduces airborne contamination load.

Intraoperative wound lavage

Intraoperative antiseptic lavage before wound closure addresses residual bacterial contamination that accumulated during surgery. Non-antibiotic antiseptic lavage options, such as Simini Protect Lavage, have been used in veterinary orthopedic surgery specifically to reduce bacteria, biofilms, and resistant organisms including MRSP at the wound before suturing.

For breaks in asepsis that allow MRSP contamination, including the specific break categories that create windows for MRSP entry into the surgical wound, that guide covers break identification and response.

MRSP and antimicrobial stewardship

MRSP's resistance pattern makes it directly relevant to antimicrobial stewardship.

Why prophylaxis often fails against MRSP:

Standard perioperative antimicrobial prophylaxis (typically cefazolin or cephalexin) targets susceptible staphylococci. MRSP is resistant to these agents by definition. Prophylaxis that covers susceptible organisms provides no meaningful protection against MRSP SSI.

Veterinary Practice News notes: "Most proposed protocols include using various dosages of cephalexin, with most SSIs involving organisms that are resistant to that drug."

The stewardship implication:

If standard prophylaxis doesn't prevent MRSP SSI, and broadening prophylaxis to agents that do cover MRSP means using antibiotics critical for human medicine (potentially violating stewardship principles), then the primary MRSP prevention strategy must be non-antibiotic.

Asepsis is that strategy.

For asepsis in orthopedic implant surgery, including the full asepsis protocol for procedures where MRSP-biofilm risk is highest, that guide covers the implant-specific asepsis requirements.

MRSP screening and pre-operative risk assessment

For high-risk procedures (TPLO, complex orthopedic reconstruction, revision surgery), pre-operative MRSP screening of the patient allows:

• Identification of carrier status before surgery
• Targeted skin decolonization protocols where indicated
• Informed decision-making about surgical scheduling and isolation precautions
• Enhanced post-operative monitoring for patients at elevated SSI risk

The Finnish outbreak study implemented admission screening as its primary outbreak control measure. Proactive pre-operative screening for elective high-risk cases applies this principle preventively.

For surgical asepsis standards for high-risk cases, including the full five-domain asepsis framework and how it applies to procedures with elevated MRSP risk, that guide covers the comprehensive asepsis standard.

Frequently asked questions

Can decolonization eliminate MRSP before surgery?

Mupirocin nasal ointment and chlorhexidine body wash protocols have been used in human medicine to decolonize MRSA carriers before elective surgery, with documented reduction in SSI rates. Equivalent veterinary protocols are less well-established, but chlorhexidine-based skin preparation in the weeks before surgery has been proposed for MRSP-positive dogs undergoing elective procedures. Consult current veterinary dermatology guidelines for specific decolonization protocols.

If MRSP SSI is so difficult to treat, why not use broader prophylaxis?

Broadening prophylaxis to agents that cover MRSP (such as vancomycin equivalents) uses antibiotics classified as critically important for human medicine. Using these agents prophylactically in veterinary patients contributes to resistance development in organisms that cross between animals and humans. This is the core stewardship dilemma: the antibiotic that would prevent MRSP SSI is the one that should be preserved for treatment of serious human infections. Asepsis resolves this dilemma by preventing the SSI without antibiotics.

Does MRSP pose a zoonotic risk to veterinary staff?

MRSP can colonize humans, particularly those in close contact with dogs. Veterinary staff who work with MRSP-positive patients or in practices with ongoing MRSP transmission have demonstrated higher colonization rates. This is an occupational health concern as well as a patient safety issue. The same hand hygiene and barrier precautions that protect patients also protect staff.

MRSP is the argument for asepsis that antibiotics cannot make. When the pathogen is resistant to the antibiotics available and forms biofilm that resists both antibiotic penetration and immune response, the only strategy that reliably prevents infection is the one that prevents the organism from entering the wound in the first place. That strategy is asepsis.

Resources

The following sources were used as reference and background for this article:

• NIH/PMC. Large Outbreak Caused by MRSP ST71 in a Finnish Veterinary Teaching Hospital. ncbi.nlm.nih.gov
• Veterinary Practice News. Old and New Thoughts on Infection Control. veterinarypracticenews.com
• NIH/PMC. Skin asepsis protocols as a preventive measure of SSI in dogs: chlorhexidine-alcohol versus povidone-iodine. ncbi.nlm.nih.gov
• Zoetis Canada. Controlling Methicillin Resistant Staphylococcus Infection Control Strategies for Veterinary Hospitals. zoetis.ca
• CAVD. What is Methicillin-resistant Staphylococcus Pseudintermedius? wormsandgermsblog.com

Sterilization and asepsis are related but distinct disciplines. Sterilization is a process applied to instruments and materials before a procedure. Asepsis is the ongoing system of practices that protect the sterility of those materials throughout the procedure.

Sterilization is the foundation. Asepsis is the discipline that preserves what sterilization achieved.

What this covers: The formal definitions of asepsis and sterilization, how sterilization supports the aseptic system, the sterilization methods used in veterinary practice, validation requirements, and the relationship between the two in clinical infection control.Core distinction: Sterilization achieves a state: the complete elimination of all microorganisms and spores from an object. Asepsis maintains a state: the prevention of contamination from entering the operative field or patient.Clinical relevance: Sterilization failure is the highest-consequence single point of failure in surgical asepsis. A contaminated instrument delivered via perfect aseptic technique still introduces bacteria directly into the wound. Validating sterilization efficacy is therefore not optional: it is the most critical quality control step in the instrument cycle.

Key takeaways

• Sterilization destroys all microorganisms including spores; disinfection does not: This is the critical distinction between sterilization and lower-level microbial control methods.
• Asepsis depends on sterilization as its starting point: Aseptic technique manages sterile items to prevent re-contamination. If those items were not sterile to begin with, aseptic technique has no valid starting point.
• Chemical indicators confirm exposure, not sterility: A darkened chemical indicator on an instrument pack confirms the pack was exposed to a sterilization cycle. It does not confirm that cycle achieved sterility. Only biological indicators confirm functional sterility.
• Biological indicator testing must be performed regularly: Weekly biological indicator tests are the minimum for active veterinary surgical practices. Any failed test requires removal of all potentially affected packs from use.
• Sterilization methods are not interchangeable: Autoclave (steam sterilization), dry heat, ethylene oxide, and chemical sterilization each have different indications and limitations. Selecting the wrong method for an instrument type risks either sterilization failure or instrument damage.
• Aseptic technique preserves what sterilization achieved: A sterile pack that is opened incorrectly, stored past its expiry date, or handled with non-sterile technique is no longer sterile regardless of the quality of the sterilization cycle it underwent.

Formal definitions

Sterilization

The complete destruction of all microorganisms, including bacterial spores, on an object or material.

Veterian Key defines sterilization as "the destruction of all microorganisms (bacteria, viruses, spores) on an item."

Sterilization achieves an absolute outcome: zero viable microorganisms. This distinguishes it from disinfection, which reduces but does not eliminate all microbial life, and from antisepsis, which reduces microbial load on living tissue.

Sterility assurance level (SAL): In practice, sterilization is described probabilistically. A SAL of 10^-6 means there is a 1 in 1,000,000 probability that any viable microorganism remains after the process. Validated sterilization methods are designed to achieve this standard.

Asepsis

The prevention of contamination of sterile environments, tissues, or materials by pathogenic microorganisms.

Asepsis is not a single action but a system: the combination of sterile technique, physical barriers, environmental controls, and behavioral protocols that maintain contamination-free conditions from the moment of instrument sterilization through wound closure.

The relationship: sterilization creates a sterile item; asepsis keeps it sterile until it reaches the patient.

Sterilization methods in veterinary practice

Steam sterilization (autoclave)

The primary method for metal instruments, textiles, and most reusable surgical supplies.

Mechanism: High-pressure saturated steam denatures proteins and destroys cell membranes across all microorganism types including spores.

Standard parameters:

• Gravity displacement cycle: 121°C at 15 psi for 15 minutes
• Pre-vacuum cycle: 132°C for 4 minutes (faster; requires functional vacuum pump)

Advantages: Reliable, fast, low-cost per cycle, no toxic residues.

Limitations: Cannot be used for heat-sensitive instruments (flexible endoscopes, some electronic components, plastics that melt or warp).

Dry heat sterilization

Mechanism: Oxidation of cellular components at high temperature without moisture.

Parameters: 160°C for 120 minutes; 170°C for 60 minutes.

Indications: Instruments that corrode with moisture (some cutting edges, certain alloys). Powders and oils that steam cannot penetrate.

Limitations: Longer cycle times; higher energy cost; not suitable for heat-sensitive materials.

Chemical sterilization (liquid sterilants)

Mechanism: Alkylation or oxidation of microbial proteins and nucleic acids.

Agents and contact times:

• Glutaraldehyde 2%: 6 to 10 hours for sterilization (versus 20 to 30 minutes for high-level disinfection only)
• 7.5% hydrogen peroxide: 6 hours at 20°C for sterilization

Indications: Heat-sensitive critical devices that cannot be autoclaved (some arthroscopes, fiber-optic equipment).

Limitations: Items must be fully immersed; residual agent must be rinsed before use; sterility is not maintained after removal from solution unless aseptic transfer is used.

Ethylene oxide (EtO) gas sterilization

Mechanism: Alkylation of DNA and proteins; kills all microorganisms including resistant spores.

Indications: Heat-sensitive and moisture-sensitive devices (some electronic implants, complex optics).

Limitations: Requires specialized equipment and aeration period (12 to 24 hours) to remove toxic residues before clinical use. High cost; not practical for most general veterinary practices.

For how sterilization is validated, including biological indicator protocols, chemical indicator interpretation, and what to do when a sterilization cycle fails, that guide covers the validation process in full.

Sterilization validation: the quality control bridge

Sterilization cannot be assumed. It must be confirmed. The three-level monitoring system:

Level 1: Mechanical monitoring

Recording temperature, pressure, and time for each autoclave cycle. Modern autoclaves print cycle records automatically. These records should be filed and reviewed periodically as part of the clinic's quality system.

Mechanical monitoring confirms the autoclave ran a cycle. It does not confirm the cycle achieved sterility.

Level 2: Chemical indicators

Chemical indicator strips and integrators inside and outside instrument packs change appearance when exposed to sterilization conditions.

• External indicators confirm the pack was exposed to a cycle
• Internal indicators confirm the sterilizing agent penetrated the pack interior
• Class 5 and 6 integrating indicators provide the closest chemical approximation to a sterility confirmation

Critical limitation: Chemical indicators confirm exposure to sterilization conditions. They do not confirm the biological kill standard was met.

Level 3: Biological indicators (spore tests)

Biological indicators contain Geobacillus stearothermophilus spores (the most resistant organism to steam sterilization). If the autoclave cycle kills these spores, it confirms the cycle achieved the required sterility standard.

Biological indicators are the only confirmation of functional sterilization efficacy.

Recommended frequency: weekly in active veterinary surgical practices; after any autoclave service or malfunction; when a chemical indicator failure is observed.

For the instrument sterilization protocol, including the step-by-step process from instrument cleaning through packaging, sterilization, storage, and shelf-life management, that guide covers the full instrument reprocessing protocol.

How asepsis preserves sterilization

Sterilization achieves sterility at a point in time. Asepsis is what preserves that sterility from that point through wound closure.

The chain of asepsis after sterilization:

1. Pack integrity maintained during storage: No tears, moisture, or compromised seals
2. Expiry date respected: Sterility is time-limited; shelf-life management is part of the asepsis system
3. Sterile opening technique: Circulating nurse opens the pack without contacting the sterile contents; contents dropped or transferred to the sterile field without touching the non-sterile outer packaging
4. Aseptic instrument handling: Instruments handled only by gowned, gloved scrub personnel; not dropped below table level; not contaminated by non-sterile contact
5. Sterile field maintenance: Entire operative period managed to prevent any non-sterile item from contacting sterile instruments or the wound

If any step in this chain fails, the sterilization was wasted. An instrument that was sterile when packed but handled with non-sterile technique at the table is contaminated before it enters the wound.

For aseptic technique applied to preserving sterility, including the specific intraoperative behaviors that protect sterile instruments from re-contamination, that guide provides the technique reference that complements sterilization.

Sterilization sits at the top of the microbial control hierarchy, above both disinfection and antisepsis. Understanding where each level applies prevents the common error of applying a lower standard than the clinical situation requires. For disinfection vs. asepsis comparison, including how the three levels of disinfection compare to sterilization and when each applies in veterinary practice, that guide covers the Spaulding classification and the full hierarchy of microbial control.

For antisepsis in the broader asepsis framework, including how antisepsis applied to living tissue relates to sterilization of instruments within the same perioperative infection control system, that guide covers the complementary antisepsis component.

Common failures at the sterilization-asepsis interface

Frequently asked questions

Is sterilization the same as disinfection at a higher level?

No. Disinfection reduces microbial load and kills most pathogens but does not reliably kill all bacterial spores. Sterilization destroys all microorganisms including spores and achieves an absolute sterility standard. High-level disinfection can approach sterilization with extended contact times, but the two are formally distinct levels of microbial control with different validation standards.

How long do sterilized packs remain sterile?

This depends on packaging type and storage conditions. Event-related sterility is the current standard: a pack remains sterile until something happens to compromise it (moisture exposure, torn packaging, improper storage), rather than a fixed time period. Many clinics use a defined shelf life (e.g., 6 months for double-wrapped packs in clean, dry storage) as a practical policy even though the scientific standard is event-related.

What should happen if a biological indicator comes back positive?

All packs sterilized since the last successful biological indicator test should be removed from use immediately. The autoclave should be taken out of service, inspected, and repaired. A new biological indicator should be run before the autoclave returns to service. All clinical cases performed using instruments from potentially non-sterile packs should be flagged for post-operative monitoring. Document the incident and all corrective actions.

Can aseptic technique compensate for a failed sterilization cycle?

No. If an instrument is not sterile, no amount of correct aseptic technique during the procedure prevents the contamination it carries from entering the wound. Sterilization is a prerequisite. Asepsis preserves it. Neither substitutes for the other.

Sterilization and asepsis are not competing approaches or different words for the same thing. Sterilization is the process that creates the starting condition for safe surgery. Asepsis is the system of practices that maintains that condition. Both must function correctly for surgical infection control to hold.

Resources

The following sources were used as reference and background for this article:

• Veterian Key. Sterilization and Disinfection. veteriankey.com
• Today's Veterinary Nurse. Keys to Successful High-Level Disinfection and Sterilization Processes. todaysveterinarynurse.com
• GWU Office of Research Safety. Sterilization, Disinfection, and Decontamination. researchsafety.gwu.edu
• Wiley Online Library. Disinfection and Sterilization, Veterinary Microbiology. onlinelibrary.wiley.com

Orthopedic surgery in dogs carries higher SSI rates than most other surgical categories. The combination of complex anatomy, prolonged procedure times, tissue trauma from bone work, and the frequent use of implants creates a surgical environment where asepsis must be applied with particular rigor.

What this covers: The asepsis protocol for orthopedic surgery in dogs, including pre-operative preparation, intraoperative standards, and post-operative wound management. Both implant and non-implant orthopedic procedures are addressed, with specific attention to where requirements differ.Evidence base: TPLO SSI retrospective cohorts; veterinary orthopedic surgical site infection incidence data; intraoperative bacterial contamination survey (Vet Surg, Andrade et al., 2016); MRSP colonization as SSI risk factor.SSI rate context: SSI rates in veterinary orthopedic surgery range from approximately 3% to 18%, with the highest rates in procedures involving implants and joints (TPLO: 0.8 to 14.3%; arthrodesis: up to 25%). These rates are substantially higher than for clean soft tissue procedures (1 to 5%).

Key takeaways

• Orthopedic SSI rates are higher than soft tissue SSI rates across all procedure types.
• MRSP colonization is a documented significant risk factor for orthopedic SSI.
• Prolonged procedure time increases SSI risk; minimize through efficient technique.
• Bone work (saw, drill) generates aerosolized contamination near the sterile field.
• Implant procedures require enhanced asepsis; non-implant procedures meet standard.
• Intraoperative lavage is standard for all orthopedic procedures before closure.

Why orthopedic surgery carries elevated SSI risk

Several procedure-specific factors elevate SSI risk for canine orthopedic surgery beyond the baseline for clean soft tissue procedures:

1. Prolonged procedure time

Longer procedures increase SSI risk through cumulative contamination exposure, personnel fatigue leading to technique lapses, and extended anesthesia duration which may impair immune function. SSI risk increases with each additional hour of surgical time.

2. Bone and soft tissue trauma

Oscillating saws, drills, and osteotomes create significant local tissue trauma. Devitalized tissue is more susceptible to bacterial colonization. Thermal damage from bone cutting can further reduce local tissue viability and host defense.

3. Periosteal and soft tissue dissection

Extensive tissue dissection creates dead space. Blood and tissue fluid accumulation in dead space provides a culture medium for bacteria. Minimizing dead space through careful tissue handling and closure is part of the aseptic technique in orthopedic surgery.

4. Implant presence

When metal implants are used, the minimum infective dose required to establish infection drops dramatically. Implants provide an abiotic surface for biofilm formation that bypasses host immune defense. This is why implant procedures require a higher asepsis standard than non-implant procedures.

5. MRSP colonization

S. pseudintermedius, including MRSP strains, is commensal on canine skin and the most common cause of orthopedic SSI. MRSP colonization of the patient is a documented independent risk factor for SSI (OR 9.0 in one orthopedic cohort study).

Pre-operative asepsis: orthopedic-specific requirements

Patient preparation

Clipping:

Clip immediately before surgery. Clip margins should be generous: for extremity procedures, clip from the body wall to the distal limb. For stifle procedures (TPLO, cruciate repair), this typically means the entire limb from the groin to the paw.

A study by Andrade et al. (Vet Surg, 2016) surveyed intraoperative bacterial contamination in dogs undergoing elective orthopedic surgery, confirming that contamination is common and multifactorial. Generous clip margins reduce the zone of potential surface contamination adjacent to the incision.

Skin antisepsis:

Minimum three-pass centrifugal scrub with CHG-alcohol or PVI-alcohol combination. For limb procedures, the scrub extends to the entire clipped area.

Limb hanging:

After skin antisepsis, the limb is suspended (hung) for sterile draping to allow circumferential draping. The hanging apparatus should not contaminate the prepped site. The foot is typically covered with a sterile cohesive bandage or towel before suspension to reduce contamination from paw surfaces.

Pre-operative MRSP consideration:

For high-risk patients (previous MRSP positive culture, recent antimicrobial treatment, chronic skin disease, prior SSI at same site), pre-operative MRSP screening allows scheduling adjustments, decolonization where protocols exist, and enhanced intraoperative asepsis.

Surgical team preparation

Standard surgical hand antisepsis applies. Double gloving is recommended for all implant orthopedic procedures.

Orthopedic instrument sets:

Confirm all instruments are sterile before case start. Orthopedic instrument sets are often complex with many components; each must have chemical indicator confirmation and pack integrity verification before being opened onto the sterile field.

Intraoperative asepsis: orthopedic-specific requirements

Sterile field management

Draping for limb procedures:

Circumferential draping of the limb is standard for most extremity orthopedic procedures. This requires:

• Limb hanging in a sterile loop or stockinette suspended from an IV stand
• Initial circumferential draping with impervious drape material
• Sterile stockinette or cohesive bandage over the distal limb
• Final draping to isolate the surgical site within the sterile field

Once placed, drapes must not be repositioned. Any draped area contaminated during patient positioning must have a new sterile drape applied.

Powered instrument management:

Oscillating saws and drills generate bone and tissue debris that contaminates the surrounding sterile field. Management strategies:

• Use irrigation during bone cutting to reduce heat generation and debris dispersion
• Use sterile drapes positioned to capture contaminated material where possible
• Surgical team members not directly holding the powered instrument should step back during cutting to reduce contamination exposure

Implant insertion:

The moment of implant insertion into bone is the highest-risk moment for contamination in orthopedic surgery. The implant transitions from the sterile field into the bone canal, and any contamination of the implant surface at this moment cannot be subsequently corrected.

Implant handling standards:

• Grasped only with sterile instruments, never bare gloved hands unless using sterile technique
• Not resting on any surface below sterile field level
• Not touched by non-sterile personnel or instruments at any point

OR traffic:

Enforce strict traffic control throughout. Orthopedic procedures are often long (1 to 3+ hours). The temptation to allow additional personnel entry during extended procedures must be resisted. Each entry increases airborne contamination cumulatively across the procedure duration.

For aseptic technique applied during orthopedic procedures, including the sterile field rules, instrument handling, and personnel behavior standards that govern the intraoperative phase of all surgical procedures, that guide covers the intraoperative technique framework.

Intraoperative lavage

Wound lavage before closure is standard for all orthopedic procedures, both implant and non-implant.

Saline lavage:

Copious pulsatile or syringe-pressure saline irrigation removes:

• Loose bone fragments (sequestra)
• Blood clots and debris that would otherwise remain in dead space
• Free-floating bacteria that accumulated during surgery

Volume: typically 500 mL to 1 L for a single joint procedure; more for larger procedures.

Antiseptic lavage:

For higher-risk procedures (implant placement, MRSP-positive patient, prolonged procedure), antiseptic lavage before closure addresses residual bacterial contamination that saline alone cannot eliminate. Non-antibiotic antiseptic lavage options targeting biofilm-forming organisms have been used in veterinary orthopedic settings to reduce bacteria, biofilm, and resistant organisms before suturing.

This is a non-antibiotic contamination control step aligned with antimicrobial stewardship principles.

For asepsis requirements when implants are involved, including the enhanced asepsis protocol and the clinical rationale for each enhancement in the context of implant-associated infection risk, that guide covers implant-specific asepsis.

Procedure-specific asepsis notes

TPLO (tibial plateau leveling osteotomy)

TPLO is the highest-volume and highest-SSI-rate procedure in veterinary small animal orthopedic surgery. Key asepsis considerations:

• Entire limb prep from groin to paw
• Prolonged procedure time warrants strict OR traffic management
• Bone work with oscillating saw generates significant local contamination
• MRSP risk is the primary driver of treatment-resistant SSI in TPLO patients
• Implant presence (plate and screws) elevates the consequence of any contamination event

For TPLO-specific asepsis protocols, including the procedure-specific application of enhanced orthopedic asepsis to TPLO, that guide covers TPLO asepsis in detail.

Fracture stabilization

Trauma patients presenting for fracture repair often have wound contamination from the injury. Wound classification should be assessed before surgery:

• Closed fracture: generally Class I (clean); standard asepsis applies
• Open fracture: Class III (contaminated) or higher; enhanced protocols apply; antimicrobial therapy (not prophylaxis) indicated

Arthroscopy

Arthroscopic procedures have lower SSI rates than open orthopedic procedures. However, fluid distension media must be sterile, instruments must be sterile (high-level disinfection is not sufficient for instruments entering joint space), and skin antisepsis applies to all portal sites.

Joint replacement

Where performed, hip and elbow total joint replacement represents the highest-consequence orthopedic implant procedure. Full implant asepsis protocol, MRSP screening, and antiseptic lavage are all indicated.

For asepsis standards applied to orthopedic cases, including the five-domain surgical asepsis framework and how it applies across the full range of surgical procedures, that guide covers the broader surgical asepsis standard.

Post-operative wound management

Wound monitoring is more intensive after orthopedic surgery than after routine soft tissue procedures, reflecting the higher SSI rate and the greater treatment difficulty when infection does occur.

Monitoring schedule:

• Wound check at 48 to 72 hours post-operatively
• Suture/staple removal at 14 days
• Follow-up radiographs at defined intervals for bone healing assessment

What to monitor:

• Incision: redness, swelling, discharge, dehiscence
• Systemic signs: fever, lethargy, reduced appetite
• Limb use: sudden worsening of weight-bearing may indicate deep SSI

Early SSI (within 30 days): typically reflects intraoperative contamination.Late SSI (30 days to 12 months): may reflect biofilm maturation, licking-related contamination, or hematogenous seeding.

Any suspicion of SSI in an orthopedic patient warrants prompt veterinary assessment, bacterial culture, and sensitivity testing before antibiotic selection.

For breaks in asepsis during orthopedic procedures, including the specific break categories that are most common and consequential in orthopedic settings, that guide covers the break identification and response framework.

Frequently asked questions

Do all canine orthopedic procedures require implants?

No. Many orthopedic procedures are performed without permanent implants: cruciate ligament extracapsular repair, femoral head and neck excision, arthrotomy for joint exploration or fragment removal. Non-implant procedures carry lower SSI risk and do not require all of the implant-specific enhancements. They still require the full standard orthopedic asepsis protocol described above.

How does procedure duration affect SSI risk?

Longer procedures accumulate more contamination events, increase OR traffic needs, and may involve personnel fatigue affecting technique compliance. SSI risk increases measurably with each additional hour of surgical time. Efficient surgical technique that minimizes unnecessary tissue handling and procedure duration is itself an asepsis-related quality variable.

Is post-operative antimicrobial prophylaxis required for orthopedic procedures?

Current evidence and stewardship guidelines in both human and veterinary medicine recommend limiting prophylaxis to the perioperative period (within 60 minutes of incision; discontinued within 24 hours). Extended post-operative antimicrobial courses do not reduce SSI rates and contribute to resistance development. The goal is optimizing intraoperative asepsis and prophylaxis timing, not extending post-operative antibiotic coverage.

Orthopedic surgery in dogs demands asepsis that accounts for longer procedures, more tissue trauma, the specific risks of implants and biofilm, and the prevalence of MRSP as the dominant SSI pathogen. None of these factors are addressed by antibiotics alone. All of them are addressed by rigorous asepsis applied across every phase of the perioperative period.

Resources

The following sources were used as reference and background for this article:

• NIH/PMC. Surgical site infection after 769 Tibial Plateau Leveling Osteotomies. pmc.ncbi.nlm.nih.gov
• DVM360. Improving Infection Rates After TPLO. dvm360.com
• Veterinary Practice News. Old and New Thoughts on Infection Control. veterinarypracticenews.com
• Wiley Online Library. Surgeon and Patient Preparation to Minimize Surgical Site Complications in CCL Surgery. onlinelibrary.wiley.com
• Springer Nature. Antimicrobial prophylaxis is sufficient for acceptable SSI rate in clean orthopaedic and neurosurgeries in dogs. link.springer.com

Surgical site infections are among the most studied complications in veterinary surgery, and the evidence base for preventing them has matured significantly in the last decade.

SSIs are not inevitable. They are the outcome of cumulative failures in preparation, sterile technique, wound management, and post-operative care. Addressing each phase systematically produces the consistently low infection rates that characterize high-quality surgical centers.

Quick answer: Surgical site infection prevention in dogs requires coordinated measures across three phases. Pre-operatively: patient screening and proper skin preparation. Intraoperatively: antibiotic prophylaxis timed 30 to 60 minutes before incision, sterile technique with iodine-impregnated drapes, orthopedic gloves, and intraoperative lavage. Post-operatively: E-collar use, incision monitoring, activity restriction, and follow-up attendance. Extended surgery time is the strongest identified patient-level SSI risk factor in clean surgical procedures.

Key takeaways

• Extended surgery time is the strongest SSI risk factor in clean procedures per published veterinary evidence.
• MRSP carrier status significantly raises SSI risk: one study found a 9x higher odds ratio.
• Perioperative antibiotic prophylaxis without postoperative extension is sufficient for clean procedures.
• Iodophore-impregnated adhesive drapes and orthopedic gloves reduce contamination risk intraoperatively.
• The E-collar at home is the most important owner-controlled variable in post-operative infection prevention.
• SSI rates in canine clean surgery range from 0.8% to 21.3% depending on procedure, center, and protocol quality.

Why SSI prevention matters: the clinical and financial stakes

Surgical site infections in dogs cause measurable harm beyond the immediate complication. A study referenced by Clinician's Brief reported the economic impact of SSIs after TPLO surgery in dogs as ranging from $110.21 to $3,817.12 USD per case, depending on the intervention required. Beyond cost, SSIs extend recovery, increase antibiotic exposure, and in cases involving orthopedic implants, may require hardware removal.

SSI rates in canine surgery vary widely: Clinician's Brief reports published rates ranging from 0.8% to 21.3% of surgical cases depending on procedure type, setting, and protocol quality. This range demonstrates that SSI is not a fixed background risk: it is heavily influenced by practice decisions at every phase of surgical care.

Pre-operative SSI prevention

Patient screening and risk factor management

Not all surgical patients carry equal SSI risk. Identifying and modifying controllable risk factors before surgery reduces baseline risk:

• Active skin infections (pyoderma): must be fully resolved before elective surgery. Skin bacteria can contaminate the surgical field directly.
• MRSP carrier status: a Finnish veterinary teaching hospital study (PMC7495856) identified MRSP carriage as a significant SSI risk factor with an odds ratio of 9.0. Dogs known or suspected to carry MRSP warrant specific pre-operative screening.
• Obesity: impairs blood flow to wound edges and slows healing.
• Metabolic conditions: diabetes, Cushing's disease, and hypothyroidism all compromise immune function and wound repair.
• Higher body temperature: the same Finnish study found higher pre-operative body temperature was associated with increased SSI risk (mean difference of +0.4°C compared to dogs without SSI).

Skin preparation

The skin harbors the microorganisms most likely to contaminate a wound during surgery. Reducing skin flora at the operative site is a fundamental pre-operative measure:

• Hair is clipped, not shaved (shaving creates micro-abrasions that increase bacterial colonization)
• Chlorhexidine gluconate-based prep solution applied in a scrub-then-paint sequence
• The prepared area extends well beyond the planned incision margins
• A minimum skin preparation contact time is observed before draping

The Veterinary Nurse confirms: "Skin preparation and aseptic techniques aim to reduce or eliminate the growth of resident and transient flora at the wound site."

Intraoperative SSI prevention

Antibiotic prophylaxis: timing and duration

The evidence consistently supports perioperative antibiotic prophylaxis without postoperative extension for clean orthopedic and neurosurgical procedures in dogs.

The Finnish study (PMC7495856) found: "Antimicrobial prophylaxis without postoperative antimicrobials is sufficient to maintain the overall rate of SSI at a level similar to published data in canine clean orthopedic and neurosurgeries." Of 406 dogs reviewed, 92.9% received antimicrobial prophylaxis and only 1.1% received postoperative antimicrobials: the SSI rate was comparable to international benchmarks.

The correct protocol: intravenous cefazolin given 30 to 60 minutes before skin incision, repeated every 90 to 120 minutes intraoperatively if surgery exceeds the dosing interval.

For how antibiotic prophylaxis works within the broader SSI prevention framework, see prophylactic antibiotics in SSI prevention.

Sterile field management

Beyond antibiotics, maintaining a sterile intraoperative environment requires:

• Iodophore-impregnated adhesive drapes applied to the skin at the operative field to prevent migration of skin flora into the wound
• Orthopedic surgical gloves for implant procedures to reduce perforation risk
• Double-gloving with glove changes after draping and at the 60-minute mark for extended procedures
• Rigorous instrument handling by all operating room personnel
• Limiting operating room traffic during the procedure

Managing surgery time

Extended surgery time is the only variable identified as a significant SSI risk factor in a large-scale European study of 1,550 dogs undergoing clean procedures (ScienceDirect). Every additional minute of open wound time increases cumulative bacterial exposure. Efficient surgical technique is an infection control measure, not just a quality-of-care issue.

Intraoperative wound lavage

Lavage with sterile isotonic saline before wound closure removes blood, bone debris, and bacteria that accumulate during surgery. This is particularly important in orthopedic procedures where implant surfaces provide an adhesion substrate for bacteria.

For how biofilm forms on implants and why lavage matters, see biofilm as a driver of surgical site infections.

Wound closure technique

Anatomical layer closure without dead space prevents the fluid accumulation that bacteria exploit post-operatively. Antimicrobial suture materials (triclosan-coated) inhibit bacterial colonization of the suture itself. The published TPLO protocol change study (PMID 29878479) demonstrated that replacing staples with antimicrobial intradermal sutures was one component of a bundle that reduced implant-associated infection from 8.5% to 1.3%.

Post-operative SSI prevention

At the hospital before discharge

• Antimicrobial ointment (mupirocin) applied to the wound before bandaging
• Soft-padded bandage protecting the wound during in-hospital recovery
• E-collar placed before the dog recovers from anesthesia
• Single-use gloves for all staff handling the post-operative wound

Owner responsibilities at home

The dog's owner becomes the primary infection control agent once the dog leaves the hospital. The key measures:

E-collar compliance: the most important single owner-controlled factor. Licking delivers oral bacteria directly to the incision and can bypass every intraoperative precaution. The E-collar must remain on whenever the dog is unsupervised.

Incision monitoring: daily visual inspection to identify redness, swelling, discharge, or odor early enough to intervene before deep infection establishes.

Activity restriction: running and jumping create mechanical stress on healing tissue and can open wound layers before they've fully healed, creating dead space and infection opportunity.

Follow-up attendance: post-operative rechecks are not optional. The 10 to 14 day recheck confirms wound healing and removes sutures. The 6 to 8 week recheck (for orthopedic procedures) confirms bone healing and implant stability.

For the practical SSI prevention guide owners use at home, see practical SSI prevention guide. For comparison with SSI prevention in cats, see SSI prevention in cats for comparison. For when infections appear despite prevention, see when surgical site infections typically emerge.

For how SSI prevention in dogs specifically applies to orthopedic cases, see reducing SSI risk in orthopedic cases.

The team culture dimension

The Veterinary Nurse notes: "It is increasingly recognised that team culture can significantly affect the perioperative management of the patient and hence, the SSI risk. A proactive team culture must be cultivated and maintained."

SSI prevention isn't solely a technical matter. Every member of the surgical team must understand their role in maintaining sterile conditions. Compliance with hand hygiene, barrier precautions, and protocol steps must be consistent across all personnel and all cases, not just the highest-profile ones.

Frequently asked questions

What is the most common source of surgical site infections in dogs?

The most common source is translocation of the patient's own skin flora into the wound. The Veterinary Nurse confirms: "Translocation of endogenous microbial flora is the most common route of surgical site infection." This is why skin preparation and sterile draping matter more than environmental contamination, which is a secondary concern.

My dog had SSI after a clean surgery. What likely went wrong?

The most common contributing factors in published veterinary SSI cases are: extended surgery time, inadequate skin preparation, break in sterile technique (often glove perforation or field contamination), failure of E-collar compliance at home leading to licking, and MRSP carriage that wasn't identified pre-operatively. A culture and sensitivity test of the infection identifies the pathogen and guides appropriate treatment.

Does my dog need antibiotics to go home after surgery to prevent SSI?

For clean orthopedic procedures, the published evidence does not support routine post-operative antibiotic courses. Perioperative dosing is sufficient when technique is correct. However, individual circumstances may warrant a post-operative course: contaminated or dirty wounds, immunocompromised patients, or cases where intraoperative contamination occurred. Ask your surgeon for the specific rationale if a post-operative antibiotic course is prescribed.

SSI prevention is a system, not a single action. The surgeon controls most variables intraoperatively, but the perioperative window spans days before and weeks after. When every phase is managed well, consistently low SSI rates are achievable across a broad range of surgical procedures in dogs.

Resources

• Gronkjaer et al. Risk factors for SSI associated with clean surgical procedures in dogs. Vet J, 2021. sciencedirect.com
• Heikkinen et al. Antimicrobial prophylaxis is sufficient in clean orthopaedic and neurosurgeries in dogs. BMC Vet Res, 2020. ncbi.nlm.nih.gov
• Clinician's Brief. Bacterial Biofilms. cliniciansbrief.com
• The Veterinary Nurse. Surgical site infections: preparation, technique and perioperative prevention. theveterinarynurse.com

An autoclave that appears to be running correctly may still be failing to achieve sterilization. Mechanical displays show that a cycle ran. They do not confirm that the cycle killed everything it was supposed to kill.

This distinction is why monitoring and validation are not the same thing, and why biological indicator testing is not optional for any veterinary practice using an autoclave for surgical instrument sterilization.

What this covers: The three-level autoclave monitoring system (mechanical, chemical, biological), validation protocols, documentation requirements, monitoring schedules, and the response protocol for failed validation.Core distinction: Monitoring is continuous and occurs with every cycle. Validation is periodic and confirms the autoclave is reliably achieving functional sterility. Both are required components of a complete sterilization quality program.Clinical relevance: Dispomed (2026) notes that Class 5 chemical indicators can demonstrate that cycle parameters were reached but cannot confirm all microorganisms were killed. Biological indicators are the only method capable of validating sterilization effectiveness.

Key takeaways

• Mechanical monitoring confirms a cycle ran; it does not confirm sterility.
• Chemical indicators confirm exposure to sterilization conditions, not microbial kill.
• Biological indicators are the only confirmation of functional sterilization efficacy.
• Weekly biological indicator testing is the minimum for active surgical practices.
• A failed biological indicator requires immediate autoclave removal from service.
• Documentation of all monitoring results is a quality assurance and regulatory requirement.
• Validation must be repeated after any autoclave service, repair, or relocation.

Why monitoring and validation are both required

Monitoring

Monitoring is the routine assessment of each sterilization cycle. It confirms that the autoclave ran a cycle and that certain measurable parameters were met.

Monitoring uses mechanical readouts and chemical indicators. Both are performed with every cycle.

Validation

Validation is the periodic confirmation that the autoclave is consistently achieving functional sterility: that is, actually killing microorganisms, including the most resistant bacterial spores.

Validation uses biological indicators. It is performed weekly as a minimum in active veterinary surgical practices and after any event that could affect autoclave performance.

The relationship: Monitoring shows the cycle happened correctly on the instruments. Validation confirms the autoclave can actually sterilize. Both are required because monitoring alone does not detect all failure modes.

Level 1: Mechanical monitoring

What it measures

Temperature, pressure, and time for each autoclave cycle, recorded by the autoclave's built-in sensors and displayed or printed as a cycle record.

What it confirms

The autoclave ran a cycle with parameters within the programmed range. Most modern autoclaves print a cycle record automatically. Older units require manual recording from gauges.

What it does not confirm

Whether the items inside the chamber actually reached the required conditions. Sensor placement typically reflects chamber conditions, not pack interior conditions. A correctly reading autoclave can still fail to sterilize an overloaded or incorrectly packed chamber.

Documentation requirements

All cycle records should be filed and retained. Minimum retention: one year. Review periodically for trends (cycles consistently short, temperature anomalies, pressure irregularities).

Level 2: Chemical indicators

Classes of chemical indicators

The ISO 11140 standard defines six classes of chemical indicator, progressively more demanding in what they confirm:

What Class 5 and 6 indicators can and cannot do

Class 5 integrating indicators are the closest chemical approximation to a sterility confirmation. They react to time, temperature, and steam, and their response correlates with G. stearothermophilus spore kill requirements.

However, as Dispomed (2026) states: "Class 5 indicators can demonstrate that certain cycle parameters were reached, but they cannot confirm that all microorganisms were killed." A positive Class 5 result means sterilization conditions were likely met. It does not guarantee sterility.

Biological indicators remain the only direct confirmation.

Practical protocol

• External indicator (Class 1): On every pack; confirms the pack was in the autoclave
• Internal indicator (minimum Class 4, preferably Class 5): Inside every pack; confirms the sterilizing agent penetrated the pack
• Check the internal indicator result before placing any instrument on the sterile field
• A failed internal indicator means the pack should not be used; investigate and reprocess

Level 3: Biological indicators (spore tests)

What they are

Biological indicators (BIs) contain a standardized population of Geobacillus stearothermophilus spores: the most heat-resistant organism relevant to steam sterilization. If the autoclave cycle kills these spores, it confirms the cycle achieved the required sterility standard.

Geobacillus stearothermophilus is inactivated by exposure to 121°C saturated steam for a minimum of 20 minutes, or equivalent conditions. A negative BI result (no growth after incubation) confirms the cycle met this standard.

Types of biological indicators

Spore vials (self-contained): Most common format in veterinary practice. After the autoclave cycle, the vial is activated and incubated at 57 to 60°C for 24 to 48 hours. A color change (or growth signal in electronic readers) indicates surviving spores.

Spore strips: Paper strips impregnated with spores, placed in a Challenge Pack Device (CPD) within the autoclave. Sent to a laboratory for incubation and reading, or read on-site if an incubator and growth medium are available.

Placement within the autoclave

Biological indicators should be placed in the most challenging position within the autoclave load: the geometric center of the load for gravity displacement autoclaves, or as specified by the manufacturer for pre-vacuum autoclaves. This is where steam penetration is hardest to achieve and where sterilization is most likely to fail if the cycle is not performing correctly.

Interpreting results

For sterilization protocol that autoclave validation supports, including the complete instrument reprocessing chain from cleaning through packaging, sterilization, and storage, that guide covers the full sterilization protocol.

Validated sterilization is the prerequisite that all subsequent asepsis depends upon. Without confirmed sterile instruments, correct aseptic technique in the OR has nothing valid to protect. For how sterilization supports surgical asepsis, including the five-domain surgical asepsis framework and where instrument sterilization fits within it, that guide covers the broader perioperative asepsis system that autoclave validation enables.

Monitoring and validation schedule

Some regulatory frameworks and institutional guidelines specify more frequent biological indicator testing. Wayne State University IACUC requires biological indicator testing every 6 months at minimum for instruments used in survival surgery. The University of Illinois standard requires indicators for every re-sterilization cycle. In active veterinary surgical practices, weekly testing provides the best safety margin.

Autoclave validation: formal process

Formal validation goes beyond routine monitoring. It is a structured assessment of whether the autoclave consistently achieves the required sterility standard across variable load conditions.

Validation steps

1. Calibration: Confirm temperature sensors are calibrated and within tolerance
2. Empty chamber runs: Establish baseline cycle performance with no load
3. Challenging load runs: Run biological indicators placed in the most difficult positions within a full clinical load (worst-case configuration)
4. Documentation: Record all cycle parameters, indicator results, and pass/fail determinations
5. Review and sign-off: Results reviewed and documented by the responsible clinician or compliance officer

When validation must be repeated

• After installation of a new or replacement autoclave
• After any repair that affects the heating, pressure, or timing systems
• After relocation of the autoclave
• After any positive biological indicator result and subsequent repair
• At minimum annually as a scheduled program component

For sterilization vs. asepsis relationship, including how validated sterilization supports the aseptic technique chain that follows it, that guide covers the relationship between sterilization and asepsis.

Responding to a positive biological indicator

A positive biological indicator is a patient safety event. The response must be immediate and documented.

Required steps:

1. Remove the autoclave from service immediately. Do not run further sterilization cycles until the cause is identified and resolved.

2. Quarantine all packs sterilized since the last successful biological indicator. These packs are considered potentially non-sterile regardless of chemical indicator results.

3. Do not use any instruments from quarantined packs in surgical procedures until the autoclave is repaired and re-validated with a negative result.

4. Investigate the cause. Common causes: overloading, incorrect pack density, maintenance failure, damaged door seal, water reservoir issue, timer or temperature sensor malfunction.

5. Repair and re-validate before returning to service. Run a new biological indicator after repair; the autoclave returns to service only on a confirmed negative result.

6. Flag all cases performed using instruments from the quarantine window for enhanced post-operative SSI monitoring.

7. Document the incident and all corrective actions. This documentation serves quality assurance and regulatory compliance purposes.

For quality control as a quality control measure, including how autoclave monitoring and validation fits within the broader surgical asepsis quality control framework, that guide covers the QC architecture.

Common autoclave monitoring errors

Frequently asked questions

How long does biological indicator incubation take?

Self-contained vial BIs typically require 24 to 48 hours of incubation at 57 to 60°C. Some rapid-readout BIs can return results in 1 to 3 hours using enzyme-based detection rather than growth. Rapid BIs are particularly useful when same-day turnaround is needed. Confirm the BI type and incubation protocol match the manufacturer's instructions.

Can we use chemical indicators instead of biological indicators to reduce cost?

No. Chemical indicators confirm exposure to sterilization conditions; biological indicators confirm that conditions achieved sterilization. These are different claims. The additional cost of weekly biological indicator testing is small relative to the patient safety consequence of an undetected sterilization failure.

What does a positive control vial confirm?

A positive control vial is an unsterilized vial from the same biological indicator lot, incubated alongside the test vial. If the positive control does not show growth, the test system may have a problem (inactive spores, incubation failure) and the negative result from the test vial cannot be trusted. Always include a positive control when running biological indicator tests.

How should autoclave monitoring records be stored?

In a designated log or binder at the autoclave location, filed chronologically. Digital records are acceptable if regularly backed up. Records should be retained for a minimum of one year; longer retention is appropriate for regulatory compliance documentation.

Autoclave monitoring tells the team what happened during a cycle. Validation confirms the autoclave can achieve what it is supposed to achieve. Both are required. Neither is optional. And the biological indicator is the only instrument in the monitoring system that actually confirms an organism was killed.

Resources

The following sources were used as reference and background for this article:

• Dispomed. The Gold Standard of Sterilization: Why Biological Indicators Matter in Veterinary Practice. dispomed.com
• Wayne State IACUC. Autoclave Monitoring and Sterile Pack Storage Standards. research.wayne.edu
• University of Illinois DRS. Autoclave Waste and Validation. drs.illinois.edu
• Tuttnauer. Spore Testing for Your Autoclave: Why, How and When. tuttnauer.com
• Consteril. What Are Biological Indicators (Spore Tests)? consteril.com